Table 4. Association of high-order gene-gene interactions with EC risk by MDR analysis.
Number of loci | Best interaction models | Testing accuracy | Cross-validation consistency | P for permutation test |
---|---|---|---|---|
1 | TGFBR1 rs6478974 T>A | 0.561 | 9/10 | <0.05 |
2 | TGFB1 rs1800469 C>T, | 0.589 | 10/10 | <0.05 |
TGFBR1 rs6478974 T>A | ||||
3 | TGFB1 rs1800469 C>T, | 0.584 | 7/10 | <0.05 |
TGFBR1 rs6478974 T>A, | ||||
TGFBR1 rs10733710 G>A | ||||
4 | TGFB1 rs1800469 C>T, | 0.575 | 6/10 | <0.05 |
TGFBR1 rs6478974 T>A, | ||||
TGFBR1 rs10512263 T>C, | ||||
TGFBR1 rs10733710 G>A |
EC, endometrial cancer; MDR, multifactor dimensionality reduction; CVC, cross-validation consistency.
Bold numbers denote a statistical significance at 0.05 level.